| BIBDX | CGVIX | BIBDX / CGVIX | |
| Total Expense Ratio | 0.80 | 0.85 | 94% |
| Annual Report Gross Expense Ratio | 0.80 | 1.13 | 71% |
| Fund Existence | 18 years | 18 years | - |
| Gain YTD | -0.827 | 2.633 | -31% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000000 | 1000000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 814M | 263M | 310% |
| Annual Yield % from dividends | 1.30 | 0.64 | 203% |
| Returns for 1 year | -7.56 | 5.62 | -134% |
| Returns for 3 years | 6.21 | 21.54 | 29% |
| Returns for 5 years | 0.75 | 29.26 | 3% |
| Returns for 10 years | 15.18 | 71.86 | 21% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBAX | 62.53 | 0.47 | +0.76% |
| JPMorgan BetaBuilders Dev APAC ex-JpnETF | |||
| EZRO | 25.11 | N/A | N/A |
| AlphaDroid Defensive Sector Rotation ETF | |||
| BLW | 12.56 | -0.02 | -0.16% |
| Blackrock Limited | |||
| QVMT | 66.03 | -0.35 | -0.53% |
| Invesco S&P S&P 500 Concentrated QVM ETF | |||
| BBP | 96.39 | -0.87 | -0.89% |
| Virtus LifeSci Biotech Products ETF | |||